Fmoc-ε- Aminocaproic acid

Fmoc-ε- Aminocaproic acid is an Fmoc-protected amino acid derivative featuring a six-carbon (caproic) side chain terminating in a primary ε-amino group, classifying it as a protected lysine-like building block with an aliphatic, non-aromatic side chain. The molecule contains a free carboxyl group and an N-terminus masked by the Fmoc (9-fluorenylmethoxycarbonyl) protecting group, which controls chemoselectivity by preventing undesired amine participation during peptide coupling while leaving the ε-amino functionality available for orthogonal reactivity. In peptide chemistry and chemical biology workflows, it functions as a protected amino acid intermediate for stepwise incorporation of an aliphatic primary amine handle into peptides or peptide-related constructs, supporting subsequent derivatization or conjugation strategies that require a terminal ε-amino group.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP03104

CAS No:88574-06-5

Synonyms/Alias:88574-06-5;Fmoc-6-Ahx-OH;N-Fmoc-6-aminohexanoicacid;6-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hexanoicacid;fmoc-E-acp-oh;6-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hexanoicacid;6-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoicAcid;ST50981328;6-{{[(9H-Fluoren-9-yl)methoxy]carbonyl}amino}hexanoicAcid;Fmoc-?-Acp-OH;Fmoc-|A-Acp-OH;AC1MBSRR;N-Fmoc-6-aminocaproicacid;6-(Fmoc-amino)caproicacid;SCHEMBL25143;6-(Fmoc-amino)hexanoicacid;MLS001197251;CHEMBL1320484;04067_FLUKA;FPCPONSZWYDXRD-UHFFFAOYSA-N;MolPort-000-150-585;HMS2883B03;ZINC2149700;CF-439;STK082390

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H23NO4
M.W/Mr.
353.42

Fmoc-ε-Aminocaproic acid is an Fmoc-protected amino acid derivative featuring a six-carbon aliphatic side chain terminating in a free primary amine, paired with a stereogenic center at the alpha carbon typical of amino acid building blocks. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the alpha amine, a carboxylic acid functionality, and a side-chain primary amine that can participate in nucleophilic acylation, sulfonylation, and reductive amination chemistry. The combination of an orthogonally removable Fmoc group and an unprotected ε-amino handle enables stepwise protection/deprotection logic and selective functionalization during peptide construction or small-molecule assembly. The resulting chiral amino acid intermediate supports controlled peptide coupling at the alpha position while providing a chemically addressable site for downstream derivatization to generate tailored side-chain motifs.

1. Peptide Synthesis

Fmoc-ε-Aminocaproic acid is used in solid-phase peptide synthesis and fragment coupling workflows where the Fmoc-protected alpha amine supports standard N-Fmoc deprotection and subsequent peptide bond formation. The carboxylic acid and alpha stereocenter align with peptide coupling chemistry, while the free ε-primary amine on the caproic side chain enables side-chain functionalization either before incorporation or after assembly of the peptide scaffold. The long aliphatic spacer can reduce steric constraints around the terminal amine, which may facilitate formation of amide, urea, or sulfonamide linkages on the side chain. Downstream, the compound can be applied to generate amino acid linkers, branching points, and amine-functional peptide analogs for biochemical research and applied peptide material development.

2. Side-Chain Functionalization

Fmoc-ε-Aminocaproic acid is applied in synthetic organic chemistry to install diverse nitrogen-containing functionalities at the terminal ε-amino group while maintaining the Fmoc group as a latent handle for later deprotection. The side-chain primary amine can undergo acylation to form amides, sulfonylation to form sulfonamides, or reductive amination to introduce substituted amines, enabling targeted derivatization of the caproic spacer. The presence of the Fmoc-protected alpha amine allows chemoselective transformations that focus on the terminal amine without disrupting peptide-ready functionality. The resulting derivatives serve as intermediates for peptidomimetics, affinity reagents, and amine-bearing building blocks used in iterative fine chemical synthesis and structure-guided molecular modification.

3. Bioconjugation Chemistry

Fmoc-ε-Aminocaproic acid is suitable for bioconjugation and chemical biology workflows where a protected amino acid scaffold provides a controlled attachment point for amine-reactive coupling strategies. The free ε-primary amine can be converted into activated amide or urea-forming reagents, or it can be used directly for conjugation chemistries that target nucleophilic amines on biomolecular surfaces. The Fmoc group supports orthogonal handling during synthesis, allowing the compound or its peptide-incorporated form to be processed under conditions that preserve the conjugation-ready amine. The resulting amine-functional linkers can be employed to construct labeled peptides, antibody/peptide conjugates, or modular biomolecule tags that support downstream analytical and materials-oriented studies.

4. Protected Amino Acid Chemistry

Fmoc-ε-Aminocaproic acid is used as a chiral, N-protected amino acid intermediate for building block preparation where orthogonality between the Fmoc group and the side-chain primary amine is central to synthetic planning. The Fmoc carbamate can be removed under base-mediated conditions typical of Fmoc strategies, enabling peptide coupling at the alpha position while the ε-amino group can be protected or derivatized as needed to control chemoselectivity. The unprotected side-chain amine provides a second functional locus that can be temporarily masked with appropriate protecting groups during multi-step synthesis, then revealed for targeted conjugation or further assembly. The compound therefore functions as a practical intermediate for preparing N-Fmoc amino acid derivatives, linker units, and side-chain-functional peptides used across peptide science and applied industrial intermediate manufacturing.

5. Pharmaceutical Manufacturing

Fmoc-ε-Aminocaproic acid is relevant to pharmaceutical manufacturing and process chemistry contexts that require reproducible amino acid derivative handling for peptide-like intermediates and amine-functional linker components. The Fmoc-protected alpha amine supports robust, scalable peptide coupling logic, while the terminal ε-amino group provides a controlled site for forming salts, amide linkages, or further derivatization during downstream intermediate generation. The linear caproic spacer can influence solubility and reactivity profiles of peptide intermediates, which may be leveraged during process route design for modular synthesis. The compound can be employed in the preparation of manufacturing intermediates for research-grade peptide constructs and amine-functional chemical entities that feed into broader fine chemical production pipelines.

Abbr
Fmoc-ε- Aminocaproic acid
InChI
1S/C21H23NO4/c23-20(24)12-2-1-7-13-22-21(25)26-14-19-17-10-5-3-8-15(17)16-9-4-6-11-18(16)19/h3-6,8-11,19H,1-2,7,12-14H2,(H,22,25)(H,23,24)
InChI Key
FPCPONSZWYDXRD-UHFFFAOYSA-N
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCCCCC(=O)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Synthesis ServicesPeptide CDMOPeptide Analysis ServicesCustom Conjugation ServicecGMP Peptide ServiceEpitope Mapping ServicesPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers